717602807	717602807	CD	B-NP	O
|	|	NN	I-NP	O
TMH	TMH	NN	I-NP	O
|	|	NN	I-NP	O
77143657	77143657	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
377784	377784	CD	B-NP	O
|	|	CC	I-NP	O
9/16/2002	9/16/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Septic	Septic	NNP	I-NP	I-protein
R	R	NNP	I-NP	I-protein
knee	knee	VBD	B-VP	O
joint	joint	JJ	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/20/2002	10/20/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/13/2002	11/13/2002	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
BLEWS	BLEWS	NN	B-NP	O
,	,	,	O	O
TOMAS	TOMAS	NN	B-NP	O
696-22-46-7	696-22-46-7	CD	I-NP	O
Ville	Ville	NNP	I-NP	O
Sti	Sti	NNP	I-NP	O
Seatnibalong	Seatnibalong	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
9/10/02	9/10/02	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
PATELLA	PATELLA	NNP	B-NP	O
,	,	,	O	O
ELLIS	ELLIS	NNP	B-NP	O
G.	G.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
CEFTAZ	CEFTAZ	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
CEFTAZIDIME	CEFTAZIDIME	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
MG	MG	NN	I-NP	O
IV	IV	CD	B-NP	O
Q8H	Q8H	NN	I-NP	O
NPH	NPH	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
14	14	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
7/26	7/26	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
REG	REG	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
REGULAR	REGULAR	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAC	QAC	NNP	I-NP	O
&	&	CC	I-NP	O
HS	HS	NNP	I-NP	O
Call	Call	NNP	I-NP	O
HO	HO	NN	I-NP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
>	>	SYM	B-NP	O
400	400	CD	I-NP	O
For	For	IN	B-PP	O
BS	BS	NN	B-NP	O
<	<	SYM	O	O
200	200	CD	B-NP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
Units	Unit	NNS	I-NP	O
reg	reg	NN	B-NP	O
SC	SC	NN	I-NP	O
For	For	IN	B-PP	O
BS	BS	NNP	B-NP	O
from	from	IN	B-PP	O
201	201	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
250	250	CD	B-NP	I-DNA
give	give	VB	B-VP	O
4	4	CD	B-NP	O
Units	Unit	NNS	I-NP	O
reg	reg	NN	B-NP	O
SC	SC	NN	I-NP	O
For	For	IN	B-PP	O
BS	BS	NNP	B-NP	O
from	from	IN	B-PP	O
251	251	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
300	300	CD	B-NP	I-DNA
give	give	VB	B-VP	O
6	6	CD	B-NP	O
Units	Unit	NNS	I-NP	O
reg	reg	NN	I-NP	O
SC	SC	NN	I-NP	O
For	For	IN	B-PP	O
BS	BS	NNP	B-NP	O
from	from	IN	B-PP	O
301	301	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
350	350	CD	B-NP	I-DNA
give	give	VB	B-VP	O
8	8	CD	B-NP	O
Units	Unit	NNS	I-NP	O
reg	reg	NN	B-NP	O
SC	SC	NN	I-NP	O
For	For	IN	B-PP	O
BS	BS	NNP	B-NP	O
from	from	IN	B-PP	O
351	351	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
400	400	CD	B-NP	I-DNA
give	give	VB	B-VP	O
10	10	CD	B-NP	O
Units	Unit	NNS	I-NP	O
reg	reg	NN	I-NP	O
SC	SC	NN	I-NP	O
OXYCODONE	OXYCODONE	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
pain	pain	NN	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/15/02	8/15/02	CD	B-NP	O
by	by	IN	B-PP	O
YACKEREN	YACKEREN	NNP	B-NP	O
,	,	,	O	O
BERTRAM	BERTRAM	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DEFINITE	DEFINITE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
NARCOTICS	NARCOTICS	NNP	B-NP	O
,	,	,	O	O
PHENANTHRENES	PHENANTHRENES	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
moniter	moniter	VB	I-VP	O
TOBRAMYCIN	TOBRAMYCIN	NN	B-NP	B-protein
SULFATE	SULFATE	NN	I-NP	I-protein
80	80	CD	B-NP	I-protein
MG	MG	NN	I-NP	I-protein
IV	IV	CD	B-NP	I-protein
Q12H	Q12H	NN	I-NP	I-protein
PAXIL	PAXIL	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
PAROXETINE	PAROXETINE	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
NEURONTIN	NEURONTIN	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
GABAPENTIN	GABAPENTIN	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
300	300	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	I-protein
NEXIUM	NEXIUM	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
40	40	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
MONOPRIL	MONOPRIL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FOSINOPRIL	FOSINOPRIL	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/13/02	4/13/02	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
FOSINOPRIL	FOSINOPRIL	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Will	Will	MD	B-VP	O
d/c	d/c	NN	B-NP	O
potassium	potassium	NN	I-NP	O
.	.	.	O	O

TRICOR	TRICOR	NN	B-NP	B-protein
160	160	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
RETURN	RETURN	NNP	I-NP	O
TO	TO	NNP	I-NP	O
WORK	WORK	NNP	I-NP	O
:	:	:	O	O
Not	Not	NNP	B-NP	O
Applicable	Applicable	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Call	Call	NNP	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Pastrano	Pastrano	NNP	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Reggie	Reggie	NNP	I-NP	O
Berni	Berni	NNP	I-NP	O
,	,	,	O	O
ID	ID	NNP	B-NP	O
11/15/02	11/15/02	CD	I-NP	O
,	,	,	O	O
Call	Call	NNP	B-NP	O
Venshore	Venshore	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
follow	follow	NN	I-NP	O
up	up	RP	B-PRT	O
appointment	appointment	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Saas	Saas	NNP	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
Morphine	Morphine	NNP	B-NP	O
,	,	,	O	O
Nsaid	Nsaid	NNP	B-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
Ofloxacin	Ofloxacin	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Presumed	Presume	VBN	B-NP	O
psuedomonas-infected	psuedomonas-infected	JJ	I-NP	O
R	R	NN	I-NP	O
knee	knee	NN	I-NP	O
joint	joint	NN	I-NP	O
/	/	SYM	B-NP	O
chronic	chronic	JJ	I-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Septic	Septic	NNP	I-NP	O
R	R	NNP	I-NP	O
knee	knee	VBD	B-VP	O
joint	joint	JJ	B-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
dm	dm	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
htn	htn	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
ex	ex	NN	I-NP	O
lap	lap	NN	I-NP	O
s/p	s/p	NN	I-NP	O
mva	mva	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
tkr	tkr	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
total	total	JJ	I-NP	O
knee	knee	NN	I-NP	O
replacement	replacement	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
chronic	chronic	JJ	I-NP	O
pseudomonas	pseudomonas	NN	I-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
chronic	chronic	JJ	I-NP	O
knee	knee	NN	I-NP	O
pain	pain	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Right	Right	NNP	I-NP	O
knee	knee	NN	I-NP	O
aspiration	aspiration	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
1/11/02	1/11/02	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

PICC	PICC	NN	B-NP	O
line	line	NN	I-NP	O
placement	placement	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
7/19/02	7/19/02	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
placement	placement	NN	B-NP	O
confirmed	confirm	VBN	B-VP	O
by	by	IN	B-PP	O
CXR	CXR	NN	B-NP	B-protein
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
53F	53F	NN	B-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
R	R	NN	I-NP	O
knee	knee	NN	I-NP	O
pseudomonas	pseudomonas	NN	I-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
sustained	sustain	VBD	B-VP	O
distal	distal	JJ	B-NP	O
femur	femur	NN	I-NP	O
fracture	fracture	NN	I-NP	O
in	in	IN	B-PP	O
1974	1974	CD	B-NP	O
MVA	MVA	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
had	have	VBD	B-VP	O
nonunion	nonunion	NN	B-NP	O
of	of	IN	B-PP	O
fracture	fracture	NN	B-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
numerous	numerous	JJ	I-NP	O
surgeries	surgery	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
TKR	TKR	NN	B-NP	B-DNA
'	'	''	I-NP	I-DNA
97	97	CD	I-NP	I-DNA
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
repeated	repeat	VBN	I-VP	O
pseudomonal	pseudomonal	JJ	B-NP	O
infections	infection	NNS	I-NP	O
of	of	IN	B-PP	O
joint	joint	NN	B-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
ceftazidime	ceftazidime	NN	B-NP	O
&	&	CC	I-NP	O
tobramycin	tobramycin	NN	I-NP	O
.	.	.	O	O

Most	Most	RBS	B-NP	O
recent	recent	JJ	I-NP	O
surgery	surgery	NN	I-NP	O
21	21	CD	I-NP	O
of	of	IN	B-PP	O
April	April	NNP	B-NP	O
pt	pt	NN	I-NP	O
had	have	VBD	B-VP	O
excision	excision	NN	B-NP	O
of	of	IN	B-PP	O
draining	drain	VBG	B-VP	O
sinus	sinus	NN	B-NP	O
tracts	tract	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-VP	O
course	course	NN	B-NP	O
of	of	IN	B-PP	O
abx	abx	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
until	until	IN	B-PP	O
August	August	NNP	B-NP	O
'01	'01	CD	I-NP	O
when	when	WRB	B-ADVP	O
developed	develop	VBN	B-NP	O
recurrence	recurrence	NN	I-NP	O
of	of	IN	B-PP	O
knee	knee	NN	B-NP	O
swelling	swelling	NN	I-NP	O
with	with	IN	B-PP	O
occasional	occasional	JJ	B-NP	O
drainage	drainage	NN	I-NP	O
from	from	IN	B-PP	O
knee	knee	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
reported	report	VBD	B-VP	O
more	more	JJR	B-NP	O
difficulty	difficulty	NN	I-NP	O
controlling	control	VBG	B-VP	O
blood	blood	NN	B-NP	O
glucose	glucose	NN	I-NP	O
level	level	NN	I-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
had	have	VBD	B-VP	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
increased	increase	VBN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
&	&	CC	B-NP	O
increased	increase	VBN	I-NP	O
swelling	swelling	NN	I-NP	O
of	of	IN	B-PP	O
knee	knee	NN	B-NP	O
.	.	.	O	O

Presented	Present	VBN	B-VP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
ROM	ROM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
from	from	IN	B-PP	O
80	80	CD	B-NP	O
degrees	degree	NNS	I-NP	O
to	to	TO	B-PP	O
only	only	RB	B-NP	O
5	5	CD	I-NP	O
degrees	degree	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
2/2	2/2	CD	B-NP	O
pain	pain	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
inability	inability	NN	B-NP	O
to	to	TO	B-VP	O
bear	bear	VB	I-VP	O
weight	weight	NN	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
.	.	.	O	O

Tx	Tx	NN	B-NP	O
empirically	empirically	RB	B-ADVP	O
with	with	IN	B-PP	O
80mg	80mg	NN	B-NP	O
IV	IV	CD	I-NP	O
q12	q12	NN	I-NP	O
tobramycin	tobramycin	NN	I-NP	O
&	&	CC	I-NP	O
1000mg	1000mg	CD	I-NP	O
IV	IV	CD	I-NP	O
q8	q8	NN	I-NP	O
ceftazidime	ceftazidime	NN	I-NP	O
for	for	IN	B-PP	O
presumed	presume	VBN	B-NP	O
pseudomonal	pseudomonal	JJ	I-NP	O
joint	joint	JJ	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
d/c	d/c	NN	B-NP	O
,	,	,	O	O
R	R	NN	B-NP	O
knee	knee	NN	I-NP	O
markedly	markedly	RB	B-VP	O
improved	improve	VBN	I-VP	O
,	,	,	O	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
non-tender	non-tender	JJ	B-ADJP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
,	,	,	O	O
decreased	decrease	VBN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
increased	increase	VBD	B-VP	O
ROM	ROM	NN	B-NP	O
from	from	IN	B-PP	O
5	5	CD	B-NP	O
degrees	degree	NNS	I-NP	O
at	at	IN	B-PP	O
admit	admit	NN	B-NP	O
to	to	TO	B-PP	O
>	>	SYM	B-NP	O
40	40	CD	I-NP	O
degrees	degree	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
now	now	RB	B-ADVP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
bear	bear	VB	I-VP	O
weight	weight	NN	B-NP	O
.	.	.	O	O

Last	Last	JJ	B-NP	O
spontaneous	spontaneous	JJ	I-NP	O
drainage	drainage	NN	I-NP	O
from	from	IN	B-PP	O
knee	knee	NN	B-NP	O
was	be	VBD	B-VP	O
4/24	4/24	CD	B-NP	O
Nara	Nara	NNP	I-NP	O
Aprun	Aprun	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
tapped	tap	VBD	B-VP	O
joint	joint	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
abx	abx	NN	B-NP	O
rec	rec	NN	I-NP	O
'd	'd	MD	B-VP	O
-RRB-	-RRB-	NNP	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
13000WBC	13000WBC	NN	B-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
53000RBC	53000RBC	NNP	B-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
polys	poly	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
crystals	crystal	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
orgs	org	NNS	I-NP	O
on	on	IN	B-PP	O
gram	gram	NN	B-NP	O
stain	stain	NN	I-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
culture	culture	NN	B-NP	O
.	.	.	O	O

Knee	Knee	NN	B-NP	O
films	film	NNS	I-NP	O
show	show	VBP	B-VP	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
from	from	IN	B-PP	O
previously	previously	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
MRI	MRI	NN	I-NP	B-protein
done	do	VBN	B-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
febrile	febrile	NN	I-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
hospital	hospital	NN	B-NP	O
,	,	,	O	O
to	to	TO	B-PP	O
103	103	CD	B-NP	O
on	on	IN	B-PP	O
11/10/02	11/10/02	CD	B-NP	O
.	.	.	O	O

Bcx	Bcx	NN	B-NP	B-protein
x2	x2	NN	I-NP	I-protein
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
orgs	org	NNS	I-NP	O
.	.	.	O	O

U/A	U/A	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
:	:	:	O	O
ESR	ESR	NN	B-NP	B-DNA
24	24	CD	I-NP	I-DNA
,	,	,	O	O
CRP	CRP	NN	B-NP	O
2.57	2.57	CD	I-NP	O
.	.	.	O	O

PICC	PICC	NN	B-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
for	for	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
antibioitc	antibioitc	NN	I-NP	O
therapy	therapy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
placement	placement	NN	B-NP	O
was	be	VBD	B-VP	O
confirmed	confirm	VBN	I-VP	O
by	by	IN	B-PP	O
CXR	CXR	NN	B-NP	B-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
6wk	6wk	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
tobramycin	tobramycin	NN	B-NP	O
and	and	CC	I-NP	O
ceftazidime	ceftazidime	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
presumed	presumed	JJ	I-NP	O
pseudomonal	pseudomonal	JJ	I-NP	O
infection	infection	NN	I-NP	O
of	of	IN	B-PP	O
R	R	NN	B-NP	O
knee	knee	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
.	.	.	O	O

HTN	HTN	NN	B-NP	B-protein
.	.	.	O	O

Contined	Contine	VBN	B-VP	O
on	on	IN	B-PP	O
ACE-I	ACE-I	NN	B-NP	B-protein
with	with	IN	B-PP	O
lisinopril	lisinopril	NN	B-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
hospital	hospital	NN	B-NP	O
.	.	.	O	O

BP	BP	NN	B-NP	O
's	'	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
160	160	CD	I-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
done	do	VBN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
to	to	TO	B-VP	O
prepare	prepare	VB	I-VP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
surgical	surgical	JJ	I-NP	O
operation	operation	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
was	be	VBD	B-VP	O
nl	nl	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
usual	usual	JJ	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
monopril	monopril	NN	B-NP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

PULM	PULM	NN	B-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
done	do	VBN	B-VP	O
to	to	TO	B-VP	O
prepare	prepare	VB	I-VP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
surgical	surgical	JJ	I-NP	O
operation	operation	NN	I-NP	O
.	.	.	O	O

Showed	Show	VBD	B-VP	O
slightly	slightly	RB	B-NP	O
decreased	decrease	VBN	I-NP	O
lung	lung	NN	I-NP	B-protein
volumes	volume	NNS	I-NP	I-protein
but	but	CC	O	I-protein
otherwise	otherwise	RB	B-ADVP	I-protein
nl	nl	NN	B-NP	I-protein
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
.	.	.	O	O

Continued	Continue	VBN	B-VP	O
on	on	IN	B-PP	O
Nexium	Nexium	NN	B-NP	O
given	give	VBN	B-VP	O
past	past	JJ	B-NP	O
h/o	h/o	NN	I-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

ENDO	ENDO	NN	B-NP	B-protein
.	.	.	O	O

DM	DM	NN	B-NP	O
.	.	.	O	O

Given	Give	VBN	B-NP	O
rash	rash	NN	I-NP	O
on	on	IN	B-PP	O
forearm	forearm	NN	B-NP	O
,	,	,	O	O
Avandia	Avandia	NNP	B-NP	O
held	hold	VBD	B-VP	O
,	,	,	O	O
and	and	CC	O	O
pt	pt	NN	B-NP	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
Insulin	Insulin	NN	B-NP	B-protein
NPH	NPH	NN	I-NP	O
10	10	CD	I-NP	O
Units	Units	NNP	I-NP	O
BID	BID	NNP	I-NP	O
,	,	,	O	O
increased	increase	VBN	B-VP	O
to	to	TO	B-PP	O
14U	14U	NN	B-NP	O
bid	bid	NN	I-NP	O
.	.	.	O	O

Needs	Need	NNS	B-NP	O
f/u	f/u	NN	I-NP	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	O
for	for	IN	B-PP	O
control	control	NN	B-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
,	,	,	O	O
esp	esp	NN	B-NP	O
.	.	.	O	O

since	since	IN	B-PP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
intermittent	intermittent	JJ	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

PAIN	PAIN	NN	B-NP	B-protein
.	.	.	O	O

Well-controlled	Well-controlled	JJ	B-ADJP	O
with	with	IN	B-PP	O
oxycodone	oxycodone	NN	B-NP	O
and	and	CC	I-NP	O
neurontin	neurontin	NN	I-NP	B-protein
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

HEME	HEME	NN	B-NP	B-protein
.	.	.	O	O

PT/PTT	PT/PTT	NN	B-NP	O
checked	check	VBD	B-VP	O
in	in	IN	B-PP	O
case	case	NN	B-NP	O
of	of	IN	B-PP	O
operation	operation	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
were	be	VBD	B-VP	O
nl	nl	NN	B-NP	B-protein
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

PSYCH	PSYCH	NN	B-NP	B-protein
.	.	.	O	O

Continued	Continue	VBN	B-VP	O
on	on	IN	B-PP	O
Paxil	Paxil	NNP	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
mood	mood	NN	I-NP	O
issues	issue	NNS	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

DISPO	DISPO	NN	B-NP	B-protein
.	.	.	O	O

D/c	D/c	NN	B-NP	O
`	`	``	O	O
ed	ed	VBN	B-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
VNA	VNA	NN	B-NP	B-protein
,	,	,	O	O
with	with	IN	B-PP	O
PICC	PICC	NN	B-NP	O
line	line	NN	I-NP	O
for	for	IN	B-PP	O
6wk	6wk	NN	B-NP	O
.	.	.	O	O

course	course	NN	B-NP	O
abx	abx	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
the	the	DT	B-NP	O
Winfred	Winfred	NNP	I-NP	O
Hollis	Hollis	NNP	I-NP	O
,	,	,	O	O
ID	ID	NN	B-NP	O
on	on	IN	B-PP	O
1/14	1/14	CD	B-NP	O
at	at	IN	B-PP	O
11am	11am	NN	B-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
call	call	VB	I-VP	O
PCP	PCP	NN	B-NP	B-protein
,	,	,	O	O
Winston	Winston	NNP	B-NP	O
Felberbaum	Felberbaum	NNP	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
in	in	IN	B-PP	O
next	next	JJ	B-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
blood	blood	NN	B-NP	O
glucose	glucose	NN	I-NP	O
and	and	CC	O	O
adjust	adjust	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
dosing	dosing	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Complete	Complete	JJ	B-NP	O
6	6	CD	I-NP	O
wk	wk	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
ceftazidime	ceftazidime	NN	B-NP	O
and	and	CC	I-NP	O
tobramycin	tobramycin	NN	I-NP	O
recommendations	recommendation	NNS	I-NP	O
.	.	.	O	O

Follow-up	Follow-up	NN	B-NP	O
with	with	IN	B-PP	O
Orthopedics	Orthopedic	NNS	B-NP	O
and	and	CC	O	O
your	your	PRP$	B-NP	O
infectious	infectious	JJ	I-NP	O
disease	disease	NN	I-NP	O
doctor	doctor	NN	I-NP	O
,	,	,	O	O
Augustus	Augustus	NNP	B-NP	O
Lapier	Lapier	NNP	I-NP	O
Your	Your	PRP$	B-NP	O
Glyburide	Glyburide	NN	I-NP	O
10mg	10mg	NN	I-NP	O
BID	BID	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
NPH	NPH	NN	B-NP	B-protein
10U	10U	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
for	for	IN	B-PP	O
better	good	JJR	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
for	for	IN	B-PP	O
adjustment	adjustment	NN	B-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
insulin	insulin	NN	I-NP	B-protein
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Will	Will	MD	B-VP	O
be	be	VB	I-VP	O
d/c	d/c	NN	B-NP	O
`	`	``	O	O
ed	ed	VBN	B-VP	O
with	with	IN	B-PP	O
PICC	PICC	NN	B-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
for	for	IN	B-PP	O
6	6	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
tobra/ceftax	tobra/ceftax	NN	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
.	.	.	O	O

Will	Will	MD	O	O
f/u	f/u	NN	B-NP	O
with	with	IN	B-PP	O
Ortho	Ortho	NNP	B-NP	O
and	and	CC	I-NP	O
ID	ID	NNP	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

HTN	HTN	NN	B-NP	B-protein
controlled	control	VBN	B-VP	O
with	with	IN	B-PP	O
ACE-I	ACE-I	NN	B-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
often	often	RB	B-ADVP	O
in	in	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
160	160	CD	I-NP	O
's	's	POS	B-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

May	May	MD	B-VP	O
need	need	VBP	I-VP	O
further	further	JJ	B-NP	O
control	control	NN	I-NP	O
by	by	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Difficulty	Difficulty	NN	B-NP	O
controlling	control	VBG	B-VP	O
blood	blood	NN	B-NP	O
sugars	sugar	NNS	I-NP	O
.	.	.	O	O

To	To	TO	B-PP	O
mid-200	mid-200	NN	B-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

Have	Have	NN	B-NP	O
d/c	d/c	NN	I-NP	O
`	`	``	O	O
ed	ed	VBD	B-VP	O
glyburide	glyburide	NN	B-NP	O
and	and	CC	O	O
begun	begin	VBN	B-NP	O
NPH	NPH	NN	I-NP	O
,	,	,	O	O
starting	start	VBG	B-VP	O
at	at	IN	B-PP	O
10U	10U	NN	B-NP	O
qam	qam	NN	I-NP	O
and	and	CC	O	O
increased	increase	VBN	B-VP	O
to	to	TO	B-PP	O
14U	14U	NN	B-NP	O
bid	bid	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-NP	O
d/c	d/c	NN	I-NP	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	O
SS	SS	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
need	need	VB	I-VP	O
further	further	JJ	B-NP	O
follow-up	follow-up	NN	I-NP	O
and	and	CC	I-NP	O
adjustment	adjustment	NN	I-NP	O
by	by	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
SUDERMAN	SUDERMAN	NNP	B-NP	O
,	,	,	O	O
ALEJANDRO	ALEJANDRO	NNP	B-NP	O
G.	G.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
KP83	KP83	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
9/10/02	9/10/02	CD	I-NP	O
@	@	HYPH	B-NP	O
12	12	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

